References
- U.S. Food & Drug Administration. In vitro diagnostics - companion diagnostics, U.S. Dept. of Health & Human Services (2016). Available at: https://www.fda.gov/medicaldevices/productsandmedicalprocedures/invitrodiagnostics/ucm407297.htm. Accessed September 1, 2017.
- Conley J. Myriad, finally: supreme court surprises by not surprising. Available at: https://www.genomicslawreport.com/index.php/2013/06/18/myriad-finally-supreme-court-surprises-by-not-surprising/#more-12896. Accessed September 1, 2017.
- Seidenberg S. Business-method and software patents may go through the looking glass after Alice decision. Am Bar Assoc J. Available at: http://www.abajournal.com/magazine/article/business_method_and_software_patents_may_go_through_the_looking_glass_after
- Accessed September 1, 2017https://www.uspto.gov/sites/default/files/documents/ieg-may-2016-ex.pdf
- Glorikian, H. Commercializing novel IVDs: a comprehensive manual for success. Insight pharma reports. 2017.
- U.S. Food & Drug Administration. Premarket approval (PMA) - master files, U.S. Dept. of Health & Human Services (2017). Available at: https://www.fda.gov/medicaldevices/deviceregulationandguidance/howtomarketyourdevice/premarketsubmissions/premarketapprovalpma/ucm142714.htm. Accessed September 1, 2017.
- Id. at.
- Lloyds Register LRQA (UK). In Vitro Diagnostic Device Regulation (IVDR). Available at: http://www.lrqa.co.uk/standards-and-schemes/ivd/ivd-new-regulation/. Accessed September 1, 2017.
- Enhancing Market Openness. Intellectual property rights, and compliance through regulatory reform in Slovenia. 2011.
- World Trade Organization. WTO | intellectual property (TRIPS) - frequently-asked questions (2017). Available at: https://www.wto.org/english/tratop_e/trips_e/tripfq_e.htm#GATT1947. Accessed September 1, 2017.
- Association of University Technology Managers. AUTM - about technology transfer(2017). Available at: https://www.autm.net/autm-info/about-tech-transfer/about-technology-transfer/. Accessed September 1, 2017.
- Carver, KH. “Companion Diagnostics: Evolving FDA Regulation and Issues for Resolution.” In Vitro Diagnostics: The Complete Regulatory Guide. Ed. Danzis, SD; Flannery, EJ: Food and Drug Law Institute, 2010:149–184.
- Gaffney A. FDA finalizes policy on use, approval of companion diagnostics. Available at: http://www.raps.org/Regulatory-Focus/News/2014/07/31/19907/FDA-Finalizes-Policy-on-Use-Approval-of-Companion-Diagnostics/. Accessed September 1, 2017.
- Hamada T, Keum N, Nishihara R, et al. Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. J Gastroenterol. 2017;52(3):265–275.
- Campbell PT, Rebbeck TR, Nishihara R, et al. Proceedings of the third international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control. 2017;28(2):167–176.
- Cremolini C, Morano F, Moretto R, et al. Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study. Ann Oncol. 2017. DOI:10.1093/annonc/mdx546
- Sissung TM, McKeeby JW, Patel J, et al. Pharmacogenomics implementation at the National Institutes of Health Clinical Center. J Clin Pharmacol. 2017;57(Suppl 10):S67–s77.